Skip to main content
SpringerLink
Log in

PPI-Refractory GERD: an Intriguing, Probably Overestimated, Phenomenon

  • Invited Commentary
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol. 1998;10:119–24.

    Article  CAS  PubMed  Google Scholar 

  2. Inadomi JM, McIntyre L, Bernard L, et al. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol. 2003;98:1940–4.

    Article  CAS  PubMed  Google Scholar 

  3. Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut. 2012;61:1340–54. In this review, that address very completely the management of GERD patients unresponsive to PPI therapy, the Authors provide a clear definition of PPI-refractory reflux symptoms.

    Article  CAS  PubMed  Google Scholar 

  4. Kahrilas PJ, Boeckstaens G. Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients? Gut. 2012;61:1501–9. This paper provides a summary of PPI efficacy in patients with different manifestations of GERD. The results are expressed in terms of therapeutic gain in comparison with placebo and clearly indicate that the greatest PPI success occurred in patients with esophagitis or typical reflux symptoms.

    Article  PubMed  Google Scholar 

  5. Poh CH, Gasiorowska A, Navarro-Rodriguez T, Willis MR, Hargadon D, Noelck N, et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc. 2010;71:28–34.

    Article  PubMed  Google Scholar 

  6. Garcia-Compean D, Gonzalez Gonzalez JA, Marrufo Garcia CA, et al. Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: a prospective study. Dig Liver Dis. 2011;43:204–8.

    Article  PubMed  Google Scholar 

  7. Hemmink GJM, Bredenoord AJ, Weusten Bas LAM, Monkelbaan JF, Timmer R, Smout Andrèe JPM. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: ‘on’ or ‘off’ proton pump inhibitor? Am J Gastroenterol. 2008;103:2446–53.

    Article  PubMed  Google Scholar 

  8. Zerbib F, Belhocine K, Simon M, et al. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease. Gut. 2012;61:501–6. This paper reports clinical findings and reflux parameters in patients not-responding to PPIs . It is one of the few studies that show the prevalence of functional heartburn in this group of patients.

    Article  CAS  PubMed  Google Scholar 

  9. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398–402.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol. 2006;101:1956–63.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Fabio Baldi declares no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the author.

Author information

Authors and Affiliations

  1. Center for the Study of Diseases of the Esophagus, University of Bologna, Bologna, Italy

    Fabio Baldi

  2. GVM Care and Research, Cotignola, RA, Italy

    Fabio Baldi

Authors
  1. Fabio Baldi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabio Baldi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baldi, F. PPI-Refractory GERD: an Intriguing, Probably Overestimated, Phenomenon. Curr Gastroenterol Rep 17, 25 (2015). https://doi.org/10.1007/s11894-015-0451-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11894-015-0451-3

Keywords

Search

Navigation